In this session the Department for International Trade and British Consulate Jeddah will offer insight into life sciences across the UK and KSA, before hearing from a series of cutting-edge UK companies that are addressing global health challenges including cancer, diabetes, obesity and mental health.
Speakers:
The Department for International Trade and British Consulate Jedda
Umaima Ahmad, CEO & Co-Founder, 52 North Health
Umaima Ahmad is CEO & Co-Founder of 52 North Health, a company developing North Health developing affordable, patient-centred and fully-integrated clinical, AI and medical-device based system. Umaima is a Business development professional and qualified lawyer with an MPhil in Bioscience Enterprise and 12 years of commercial experience. An experienced negotiator of multi-million pound pharmaceutical asset transactions.
Andy Sutcliffe, Global Strategic Marketing Director, Medtrade
Andy is currently the Global Strategic Marketing Director for Medtrade Ltd a highly successful UK based biotechnology company developing and launching industry-leading biomedical solutions across Trauma, Haemostasis, Obstetrics and Wound care sectors. With over 30 years’ experience in medical devices and infection prevention, Andy has held several senior executive marketing and commercial roles, in both SME and Fortune 500 companies, and played a significant part in the conception, development and launch of many significant innovations and ground-breaking developments across orthopaedics, trauma, infection prevention, robotics and the obstetrics field.
Dharmesh Mehta, Business Development Director, CanCertain
Dharmesh Mehta is Business Development Director for CanCertain, which uses advanced 3D cell culture techniques to help both patients and oncologists find the optimal cancer treatment using their own cancer cells rather than rely on guidance from NGS tests alone. Their technology and approach is both disruptive and highly effective with 90& accuracy in identifying effective and ineffective treatment options allowing oncologists to make an informed treatment decision. Dharmesh has a background in working with both life sciences businesses and start ups with novel concepts that have the potential to change the landscape and has helped develop them into commercial and viable businesses.
James Roberts, Founder and CEO, mOm Incubators
James Roberts is the co-Founder and CEO of mOm Incubators Ltd. mOm was founded to give every child the best start in life through smarter healthcare technology. Its first product the mOm essential Incubator is the world’s first compact, portable, and accessible neonatal Incubator and since regulatory approval in March has been deployed in multiple countries including the UK and Ukraine. An Alumni of the design school at Loughborough University, James has been recognised as one of the MIT 35 under 35, is an inductee into the Royal Academy of Engineering's enterprise hub and winner of the JC Gammon prize for Entrepreneurship and innovation. He was the overall global winner of the 2014 James Dyson Award for innovation and was named as one of MedTech's rising stars by MDDI
Dr Jason McKeown, CEO, Neurovalens
Dr. Jason McKeown is the CEO & Founder of Neurovalens, a health-tech start-up that creates non-invasive tech wearable devices (based on neuroscience research) that help improve the lives of those who suffer from neurological issues, such as obesity and insomnia. Dr. Jason McKeown is a UK trained medical physician with an interest in the neurological aspect of obesity, diabetes and metabolism. His current roles are based at both the University of California, San Diego where he holds a Visiting Scholar position at the Centre for Brain & Cognition, and also at Queen’s University of Belfast where he holds an MD Research Position at the school of Medicine.
Location: ABHI & DIT Stand: Hall 2, D30